A clinical trial to study the effect of drug NANNARI VER OORAL KUDINEER in VALI AZHAL KEEL VAYU( Rheumatoid arthritis)

A prospective open labelled phase II Non randomized clinical trial on herbal formulation of NANNARI VER OORAL KUDINEER for the treatment of VALI AZHAL KEEL VAYU(Rheumatoid arthritis)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/06/014450

Enrollment

Registered

2018-06-07

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- VALI AZHAL KEEL VAYU

Interventions

Intervention1: NANNARI VER OORAL KUDINEER: 90ml Orally Thrice a day Before food for 30 days Control Intervention1: Not applicable: Not applicable

Eligibility

Inclusion criteria

Inclusion criteria: Symmetrical joint involvement Arthritis of 3 or more joints Florid morning stiffness and swelling that lasts for few hours or days Pain joints swelling especially in the interphalangeal joints Pain criteria score should be greater than or equal to 6

Exclusion criteria

Exclusion criteria: Age below 18 and above 50 years Gouty arthritis Psoriatic arthritis Mixed connective tissue disorders SLE Extra pulmonary tuberculosis Other auto immune disease Chronic kidney disease Pregnant women and lactating mothers

Design outcomes

Primary

Measure	Time frame
Therapeutic efficacy of trial drug nannari ver ooral kudineer in vali azhal keel vayuTimepoint: 30 days	—

Secondary

Measure	Time frame
Evaluation of siddha diagnostic parameters safety of trial drug pharmacological and Biochemical analysis of trial drugTimepoint: 30 days	—

Countries

India

Contacts

Public ContactG Subash Chandran MD Siddha PhD

Govt Siddha Medical College and Hospital Palayamkottai

siddhadrgs21@gmail.com9443358271

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026